A novel Na+-Independent alanine-serine-cysteine transporter 1 inhibitor inhibits both influx and efflux of D-Serine

Journal of Neuroscience Research

Volumn 94, Issue 10, 2016, Pages 888-895

  Sakimura, Katsuya ^a   Nakao, Kenji ^a   Yoshikawa, Masato ^a   Suzuki, Motohisa ^a   Kimura, Haruhide ^a  

^a TAKEDA PHARMACEUTICAL COMPANY LIMITED   (Japan)

Author keywords

asc 1 inhibitor; D serine; efflux; microdialysis; schizophrenia

Indexed keywords

AMINO[1 (3,5 DICHLOROPHENYL) 3,5 DIMETHYL 1H PYRAZOL 4 YL]ACETIC ACID; DEXTRO SERINE; SODIUM GLUCOSE COTRANSPORTER INHIBITOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; ASTROCYTE; ASTROCYTE CULTURE; CHO CELL LINE; CONTROLLED STUDY; EFFUSION; HIGH THROUGHPUT SCREENING; HIPPOCAMPUS; IC50; IN VITRO STUDY; MICRODIALYSIS; NONHUMAN; PRIORITY JOURNAL; RAT; SCHIZOPHRENIA;

EID: 84982234160     PISSN: 03604012     EISSN: 10974547     Source Type: Journal    
DOI: 10.1002/jnr.23772     Document Type: Article

References (29)

1. Bendikov I, Nadri C, Amar S, Panizzutti R, De Miranda J, Wolosker H, Agam G. 2007. A CSF and postmortem brain study of D-serine metabolic parameters in schizophrenia. Schizophr Res 90:41–51.
2. Brown JM, Hunihan L, Prack MM, Harden DG, Bronson J, Dzierba CD, Gentles RG, Hendricson A, Krause R, Macor JE, Westphal RS. 2013. In vitro characterization of a small molecule inhibitor of the alanine serine cysteine transporter-1 (SLC7A10). J Neurochem 129:275–283.
3. Deves R, Krupka RM. 1979. A general kinetic analysis of transport. Tests of the carrier model based on predicted relations among experimental parameters. Biochim Biophys Acta 556:533–547.
4. +-independent neutral amino acid transporter that associates with the 4F2 heavy chain and exhibits substrate selectivity for small neutral D- and L-amino acids. J Biol Chem 275:9690–9698.
5. Hashimoto K, Engberg G, Shimizu E, Nordin C, Lindstrom LH, Iyo M. 2005. Elevated glutamine/glutamate ratio in cerebrospinal fluid of first episode and drug naive schizophrenic patients. BMC Psychiatry 5:6.
6. Helboe L, Egebjerg J, Moller M, Thomsen C. 2003. Distribution and pharmacology of alanine-serine-cysteine transporter 1 (asc-1) in rodent brain. Eur J Neurosci 18:2227–2238.
7. Ishimaru M, Kurumaji A, Toru M. 1994. Increases in strychnine-insensitive glycine binding sites in cerebral cortex of chronic schizophrenics: evidence for glutamate hypothesis. Biol Psychiatry 35:84–95.
8. Ishiwata S, Ogata S, Umino A, Shiraku H, Ohashi Y, Kajii Y, Nishikawa T. 2013. Increasing effects of S-methyl-L-cysteine on the extracellular D-serine concentrations in the rat medial frontal cortex. Amino Acids 44:1391–1395.
9. Karasawa J, Hashimoto K, Chaki S. 2008. D-serine and a glycine transporter inhibitor improve MK-801-induced cognitive deficits in a novel object recognition test in rats. Behav Brain Res 186:78–83.
10. Krystal JH, Karper LP, Seibyl JP, Freeman GK, Delaney R, Bremner JD, Heninger GR, Bowers MB Jr, Charney DS. 1994. Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses. Arch Gen Psychiatry 51:199–214.
11. Kuepper R, Skinbjerg M, Abi-Dargham A. 2012. The dopamine dysfunction in schizophrenia revisited: new insights into topography and course. Handb Exp Pharmacol 212:1–26.
12. Labrie V, Wong AH, Roder JC. 2012. Contributions of the D-serine pathway to schizophrenia. Neuropharmacology 62:1484–1503.
13. Matsuo H, Kanai Y, Tokunaga M, Nakata T, Arthit C, Ishimine H, Tsukada S, Ooigawa H, Nawashiro H, Kobayashi Y, Fukuda J, Endou H. 2004. High affinity D- and L-serine transpoter asc-1: cloning and dendritic localization in the rat cerebral and cerebellar cortices. Neurosci Lett 358: 123–126
14. Nunes EA, MacKenzie EM, Rossolatos D, Perez-Parada J, Baker GB, Dursun SM. 2012. D-serine and schizophrenia: an update. Expert Rev Neurother 12:801–812.
15. Onishi T, Iwashita H, Uno Y, Kunitomo J, Saitoh M, Kimura E, Fujita H, Uchiyama N, Kori M, Takizawa M. 2011. A novel glycogen synthase kinase-3 inhibitor 2-methyl-5-(3-{4-[(S)-methylsulfinyl]phenyl}-1-benzofuran-5-yl)-1,3,4-oxadiazole decreases tau phosphorylation and ameliorates cognitive deficits in a transgenic model of Alzheimer's disease. J Neurochem 119:1330–1340.
16. Ribeiro CS, Reis M, Panizzutti R, de Miranda J, Wolosker H. 2002. Glial transport of the neuromodulator D-serine. Brain Res 929:202–209.
17. Rosenberg D, Kartvelishvily E, Shleper M, Klinker CM, Bowser MT, Wolosker H. 2010. Neuronal release of D-serine: a physiological pathway controlling extracellular D-serine concentration. FASEB J 24:2951–2961.
18. Rosenberg D, Artoul S, Segal AC, Kolodney G, Radzishevsky I, Dikopoltsev E, Foltyn VN, Inoue R, Mori H, Billard JM, Wolosker H. 2013. Neuronal D-serine and glycine release via the asc-1 transporter regulates NMDA receptor-dependent synaptic activity. J Neurosci 33:3533–3544.
19. Ross CA, Margolis RL, Reading SA, Pletnikov M, Coyle JT. 2006. Neurobiology of schizophrenia. Neuron 52:139–153.
20. Rutter AR, Fradley RL, Garrett EM, Chapman KL, Lawrence JM, Rosahl TW, Patel S. 2007. Evidence from gene knockout studies implicates asc-1 as the primary transporter mediating d-serine reuptake in the mouse CNS. Eur J Neurosci 25:1757–1766.
21. Safory H, Neame S, Shulman Y, Zubedat S, Radzishevsky I, Rosenberg D, Sason H, Engelender S, Avital A, Hulsmann S, Schiller J, Wolosker H. 2015. The alanine-serine-cysteine-1 (asc-1) transporter controls glycine levels in the brain and is required for glycinergic inhibitory transmission. EMBO Rep 16:590–598.
22. Sason H, Billard JM, Smith GP, Safory H, Neame S, Kaplan E, Rosenberg D, Zubedat S, Foltyn VN, Christoffersen CT, Bundgaard C, Thomsen C, Avital A, Christensen KV, Wolosker H. 2016. Asc-1 transporter regulation of synaptic activity via the tonic release of d-serine in the forebrain. Cereb Cortex [E-pub ahead of print].
23. Shao Z, Kamboj A, Anderson CM. 2009. Functional and immunocytochemical characterization of D-serine transporters in cortical neuron and astrocyte cultures. J Neurosci Res 87:2520–2530.
24. Shimazaki T, Kaku A, Chaki S. 2010. D-serine and a glycine transporter-1 inhibitor enhance social memory in rats. Psychopharmacology 209:263–270.
25. Taffe MA, Davis SA, Gutierrez T, Gold LH. 2002. Ketamine impairs multiple cognitive domains in rhesus monkeys. Drug Alcohol Depend 68:175–187.
26. Thomsen C, Helboe L, Egebjerg J. 2003. Use of asc-1 inhibitors to treat neurological and psychiatric disorders. Patent No. WO2003077998A1
27. Tsai G, Yang P, Chung LC, Lange N, Coyle JT. 1998. D-serine added to antipsychotics for the treatment of schizophrenia. Biol Psychiatry 44:1081–1089.
28. Xie X, Dumas T, Tang L, Brennan T, Reeder T, Thomas W, Klein RD, Flores J, O'Hara BF, Heller HC, Franken P. 2005. Lack of the alanine-serine-cysteine transporter 1 causes tremors, seizures, and early postnatal death in mice. Brain Res 1052:212–221.
29. Yamamoto N, Tomita U, Umino A, Nishikawa T. 2001. Uptake of D-serine by synaptosomal P2 fraction isolated from rat brain. Synapse 42:84–86.